A Single-Arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Despite Recent Treatment With IV Bisphosphonates.

Trial Profile

A Single-Arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Despite Recent Treatment With IV Bisphosphonates.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Feb 2016

At a glance

  • Drugs Denosumab (Primary)
  • Indications Malignant hypercalcaemia
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 13 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
    • 28 Feb 2013 New source identified and integrated (M.D. Anderson Cancer Center; 2009-0595).
    • 06 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top